Weiwei Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Weiwei Yang has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Qinghua Li
Department of Occupational and Environmental Health, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China; School of Public Health, Weifang Medical University, Weifang, 261053, Shandong, China
5 shared publicationsCuijuan Zhang
Department of Obstetrics, Affiliated Hospital of Shandong Second Medical University
4 shared publicationsYuhan Meng
Center of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University
4 shared publicationsHaiqin Huang
3 shared publicationsYanru Si
School of Biosciences and Biotechnology, Weifang Medical University, Weifang, Shandong, China
3 shared publicationsZhifang Pan
School of Biosciences, Weifang Medical University, Weifang, 261053, Shandong, China
3 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1734660
Natural killer cells in preeclampsia: an overview of current research
Background: Preeclampsia is a pregnancy disorder endangering maternal and fetal health, often accompanied by complications such as hypertension and proteinuria. Natural killer cells are indispensable in the occurrence and development of preeclampsia. Up to now, there has been no bibliometric study on NK cells and preeclampsia. Thus, we conducted a bibliometric analysis based on a systematic literature retrieval strategy. Methods: Publications related to NK cells and preeclampsia were retrieved from the Web of Science Core Collection and PubMed databases. CiteSpace and VOSviewer were applied to analyze publication trends, collaboration networks, co-citation patterns, and research hotspots. Results: The findings indicated that the prevailing research focal points in this domain predominantly encompass the maternal-fetal interface in preeclampsia, inflammatory mechanisms, immune mechanisms, and other related areas. Implantation, extracellular vesicles, and oxidative stress represent the emerging hotspots in this field in recent years. Conclusion: This study has systematically summarized the future trends in preeclampsia and natural killer cells research through bibliometrics, highlighted the current research frontiers and development trends, and provided valuable references for researchers in this field.
- 18 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1734660
Open AccessNatural killer cells in preeclampsia: an overview of current research
Background: Preeclampsia is a pregnancy disorder endangering maternal and fetal health, often accompanied by complications such as hypertension and proteinuria. Natural killer cells are indispensable in the occurrence and development of preeclampsia. Up to now, there has been no bibliometric study on NK cells and preeclampsia. Thus, we conducted a bibliometric analysis based on a systematic literature retrieval strategy. Methods: Publications related to NK cells and preeclampsia were retrieved from the Web of Science Core Collection and PubMed databases. CiteSpace and VOSviewer were applied to analyze publication trends, collaboration networks, co-citation patterns, and research hotspots. Results: The findings indicated that the prevailing research focal points in this domain predominantly encompass the maternal-fetal interface in preeclampsia, inflammatory mechanisms, immune mechanisms, and other related areas. Implantation, extracellular vesicles, and oxidative stress represent the emerging hotspots in this field in recent years. Conclusion: This study has systematically summarized the future trends in preeclampsia and natural killer cells research through bibliometrics, highlighted the current research frontiers and development trends, and provided valuable references for researchers in this field.
- Open Access
- 14 November 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1279227
Exploring maternal-fetal interface with in vitro placental and trophoblastic models
The placenta, being a temporary organ, plays a crucial role in facilitating the exchange of nutrients and gases between the mother and the fetus during pregnancy. Any abnormalities in the development of this vital organ not only lead to various pregnancy-related disorders that can result in fetal injury or death, but also have long-term effects on maternal health. In vitro models have been employed to study the physiological features and molecular regulatory mechanisms of placental development, aiming to gain a detailed understanding of the pathogenesis of pregnancy-related diseases. Among these models, trophoblast stem cell culture and organoids show great promise. In this review, we provide a comprehensive overview of the current mature trophoblast stem cell models and emerging organoid models, while also discussing other models in a systematic manner. We believe that this knowledge will be valuable in guiding further exploration of the complex maternal-fetal interface.
- 14 November 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1279227
Open AccessExploring maternal-fetal interface with in vitro placental and trophoblastic models
The placenta, being a temporary organ, plays a crucial role in facilitating the exchange of nutrients and gases between the mother and the fetus during pregnancy. Any abnormalities in the development of this vital organ not only lead to various pregnancy-related disorders that can result in fetal injury or death, but also have long-term effects on maternal health. In vitro models have been employed to study the physiological features and molecular regulatory mechanisms of placental development, aiming to gain a detailed understanding of the pathogenesis of pregnancy-related diseases. Among these models, trophoblast stem cell culture and organoids show great promise. In this review, we provide a comprehensive overview of the current mature trophoblast stem cell models and emerging organoid models, while also discussing other models in a systematic manner. We believe that this knowledge will be valuable in guiding further exploration of the complex maternal-fetal interface.
- Open Access
- 1 July 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 127, 110122
The bioflavonoid quercetin improves pathophysiology in a rat model of preeclampsia
- 1 July 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 127, 110122
Open AccessThe bioflavonoid quercetin improves pathophysiology in a rat model of preeclampsia
- Open Access
- 13 May 2020
- Published by Springer Nature in Cell Death Discovery
- Vol. 6 (1) , 1-11
Elevated microRNA-125b inhibits cytotrophoblast invasion and impairs endothelial cell function in preeclampsia
Preeclampsia (PE) is a life-threatening disorder of human pregnancy affecting 5–8% of all pregnancies. Currently, PE remains an elusive complicated and heterogenous medical condition with no early marker or symptoms is recognized for this serious pregnancy complications. Here, we profiled the plasma miRNA expression patterns associated with preeclampsia and found 16 miRNAs were deregulated (p < 0.01) in patients who later developed PE. Circulating hsa-miR-125b was aberrantly upregulated in early pregnancy and significantly reduced after delivery in preeclampsia. We then investigated the underlying molecular mechanisms between miR-125b and PE in vitro. We found that upregulated miR-125b can target KCNA1 to inhibit trophoblast invasion in human trophoblast cells. Moreover, overexpression of miR-125b in HUVECs impaired endothelial cell function through GPC1. The findings indicated that upregulated miR-125b leads to impaired placentation, and an increased risk of preeclampsia, Our studies provide novel insights into the underlying mechanisms on the association of miR-125b in early pregnancy and risk of PE, miR-125b might be a more specific predictive marker and a safe therapeutic target for treating patients with PE.
- 13 May 2020
- Published by Springer Nature in Cell Death Discovery
- Vol. 6 (1) , 1-11
Open AccessElevated microRNA-125b inhibits cytotrophoblast invasion and impairs endothelial cell function in preeclampsia
Preeclampsia (PE) is a life-threatening disorder of human pregnancy affecting 5–8% of all pregnancies. Currently, PE remains an elusive complicated and heterogenous medical condition with no early marker or symptoms is recognized for this serious pregnancy complications. Here, we profiled the plasma miRNA expression patterns associated with preeclampsia and found 16 miRNAs were deregulated (p < 0.01) in patients who later developed PE. Circulating hsa-miR-125b was aberrantly upregulated in early pregnancy and significantly reduced after delivery in preeclampsia. We then investigated the underlying molecular mechanisms between miR-125b and PE in vitro. We found that upregulated miR-125b can target KCNA1 to inhibit trophoblast invasion in human trophoblast cells. Moreover, overexpression of miR-125b in HUVECs impaired endothelial cell function through GPC1. The findings indicated that upregulated miR-125b leads to impaired placentation, and an increased risk of preeclampsia, Our studies provide novel insights into the underlying mechanisms on the association of miR-125b in early pregnancy and risk of PE, miR-125b might be a more specific predictive marker and a safe therapeutic target for treating patients with PE.
- 1 September 2017
- Published by Elsevier in Toxicology
- Vol. 390, 109-116
Dysregulation of DNA methylation and expression of imprinted genes in mouse placentas of fetal growth restriction induced by maternal cadmium exposure
- 1 September 2017
- Published by Elsevier in Toxicology
- Vol. 390, 109-116
Dysregulation of DNA methylation and expression of imprinted genes in mouse placentas of fetal growth restriction induced by maternal cadmium exposure
- 1 October 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 453 (1) , 57-63
miR-125b-1-3p inhibits trophoblast cell invasion by targeting sphingosine-1-phosphate receptor 1 in preeclampsia
- 1 October 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 453 (1) , 57-63
miR-125b-1-3p inhibits trophoblast cell invasion by targeting sphingosine-1-phosphate receptor 1 in preeclampsia
- Open Access
- 4 September 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (9) , e106725
Sphingosine-1-Phosphate Promotes Extravillous Trophoblast Cell Invasion by Activating MEK/ERK/MMP-2 Signaling Pathways via S1P/S1PR1 Axis Activation
Successful placentation depends on the proper invasion of extravillous trophoblast (EVT) cells into maternal tissues. Previous reports demonstrated that S1P receptors are expressed in the EVT cells and S1P could regulate migration and function of trophoblast cells via S1P receptors. However, little is known about roles of S1P in the invasion of EVT cells. Our study was performed to investigate S1P effect on the invasion of EVT cells. We used the extravillous trophoblast cell line HTR8/SVneo cells to evaluate the effect. In vitro invasion assay was employed to determine the invasion of HTR8/SVneo cells induced by S1P. MMP-2 enzyme activity and relative level in the supernatants of HTR8/SVneo was assessed by gelatin zymography and western blot. Based on the above, siRNA and specific inhibitors were used for the intervention and study of potential signal pathways, and Real-time qPCR and western blot were used to test the mRNA and protein level of potential signal targets. We found that S1P could promote HTR8/SVneo cell invasion and upregulates activity and level of MMP-2. The promotion requires activation of MEK-ERK and is dependent on the axis of S1P/S1PR1. Our investigation of S1P may provide new insights into the molecular mechanisms of EVT invasion.
- 4 September 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (9) , e106725
Open AccessSphingosine-1-Phosphate Promotes Extravillous Trophoblast Cell Invasion by Activating MEK/ERK/MMP-2 Signaling Pathways via S1P/S1PR1 Axis Activation
Successful placentation depends on the proper invasion of extravillous trophoblast (EVT) cells into maternal tissues. Previous reports demonstrated that S1P receptors are expressed in the EVT cells and S1P could regulate migration and function of trophoblast cells via S1P receptors. However, little is known about roles of S1P in the invasion of EVT cells. Our study was performed to investigate S1P effect on the invasion of EVT cells. We used the extravillous trophoblast cell line HTR8/SVneo cells to evaluate the effect. In vitro invasion assay was employed to determine the invasion of HTR8/SVneo cells induced by S1P. MMP-2 enzyme activity and relative level in the supernatants of HTR8/SVneo was assessed by gelatin zymography and western blot. Based on the above, siRNA and specific inhibitors were used for the intervention and study of potential signal pathways, and Real-time qPCR and western blot were used to test the mRNA and protein level of potential signal targets. We found that S1P could promote HTR8/SVneo cell invasion and upregulates activity and level of MMP-2. The promotion requires activation of MEK-ERK and is dependent on the axis of S1P/S1PR1. Our investigation of S1P may provide new insights into the molecular mechanisms of EVT invasion.